XML 104 R88.htm IDEA: XBRL DOCUMENT v3.22.4
INCOME TAXES - Other (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Deferred tax assets:      
U.S. and state net operating loss carryforwards $ 56,982 $ 31,400  
Research and development credits 5,036 5,470  
Operating lease liabilities 2,131 2,321  
Returns and discounts 19,423 23,072  
Stock-based compensation 6,776 7,838  
Accruals and other 5,228 2,210  
163(j) Carryforward 3,647    
Capitalized R&D 929    
Intangible assets 23,592 12,699  
Gross deferred tax assets: 123,744 85,010  
Valuation allowance (5,254) (1,966)  
Total deferred tax assets: 118,490 83,044  
Deferred tax liabilities:      
Debt discount (406)    
Operating lease assets (1,778) (2,024)  
Inventory (3,918)    
Intangible assets (84,167)    
Property and equipment (4,271) (2,978)  
Total deferred tax liabilities: (94,540) (5,002)  
Net deferred tax assets 23,950 78,042  
Net operating loss carryforwards      
Deferred tax benefit $ 8,391 $ 78,042  
Federal corporate tax rate (as a percent) 21.00% 21.00% 21.00%
Reconciliation of gross unrecognized tax benefits - Federal, State and Foreign Tax      
Gross UTB Balance at beginning of period $ 654 $ 586 $ 578
Additions based on tax positions related to the current year   67 36
Additions for tax positions related to acquisitions 10,930    
Additions for tax positions of prior years   1  
Reductions for tax positions of prior years (184)   (28)
Gross UTB Balance at end of period 11,400 654 586
Net UTB impacting the effective tax rate at December 31 excluding valuation allowance impacts, if any 11,368 500 560
BioDelivery Sciences International, Inc      
Net operating loss carryforwards      
Net operating losses acquired 234,675    
U.S. federal      
Net operating loss carryforwards      
Net operating losses 229,797 119,280 226,824
Research and development tax credit carryforwards, net 4,231 4,503 4,623
State      
Net operating loss carryforwards      
Net operating losses 252,597 103,044 170,280
Research and development tax credit carryforwards, net $ 832 $ 955 $ 1,150